Entity Details

Primary name KANK1
Entity type gene
Source Source Link

Details

PrimaryID23189
RefseqGeneNG_016331
SymbolKANK1
NameKN motif and ankyrin repeat domains 1
Chromosome9
Location9p24.3
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1999-11-30
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsKANK1_HUMAN

GO terms

Show/Hide Table
GOName
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0005856 cytoskeleton
GO:0005886 plasma membrane
GO:0008013 beta-catenin binding
GO:0008283 cell population proliferation
GO:0010977 negative regulation of neuron projection development
GO:0030036 actin cytoskeleton organization
GO:0030177 positive regulation of Wnt signaling pathway
GO:0030336 negative regulation of cell migration
GO:0030837 negative regulation of actin filament polymerization
GO:0032587 ruffle membrane
GO:0035023 regulation of Rho protein signal transduction
GO:0035024 negative regulation of Rho protein signal transduction
GO:0046627 negative regulation of insulin receptor signaling pathway
GO:0090263 positive regulation of canonical Wnt signaling pathway
GO:0090303 positive regulation of wound healing
GO:0090521 glomerular visceral epithelial cell migration
GO:1900025 negative regulation of substrate adhesion-dependent cell spreading
GO:1900028 negative regulation of ruffle assembly
GO:2000114 regulation of establishment of cell polarity
GO:2000393 negative regulation of lamellipodium morphogenesis

Diseases

Show/Hide Table
Disease IDSourceNameDescription
612900 OMIMCerebral palsy, spastic quadriplegic 2 (CPSQ2)A non-progressive disorder of movement and/or posture resulting from defects in the developing central nervous system. Affected individuals manifest congenital hypotonia evolving over the first year to spastic quadriplegia with accompanying transient nystagmus and varying degrees of mental retardation. Neuroimaging shows brain atrophy and ventriculomegaly. The disease is caused by variants affecting the gene represented in this entry.